1upi

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1upi" size="450" color="white" frame="true" align="right" spinBox="true" caption="1upi, resolution 1.70&Aring;" /> '''MYCOBACTERIUM TUBERC...)
Line 1: Line 1:
-
[[Image:1upi.gif|left|200px]]<br /><applet load="1upi" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1upi.gif|left|200px]]<br /><applet load="1upi" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1upi, resolution 1.70&Aring;" />
caption="1upi, resolution 1.70&Aring;" />
'''MYCOBACTERIUM TUBERCULOSIS RMLC EPIMERASE (RV3465)'''<br />
'''MYCOBACTERIUM TUBERCULOSIS RMLC EPIMERASE (RV3465)'''<br />
==Overview==
==Overview==
-
The Mycobacterium tuberculosis rmlC gene encodes, dTDP-4-keto-6-deoxyglucose epimerase, the third enzyme in the M., tuberculosis dTDP-L-rhamnose pathway which is essential for mycobacterial, cell-wall synthesis. Because it is structurally unique, highly, substrate-specific and does not require a cofactor, RmlC is considered to, be the most promising drug target in the pathway, and the M. tuberculosis, rmlC gene was selected in the initial round of TB Structural Genomics, Consortium targets for structure determination. The 1.7 A native structure, determined by the consortium facilities is reported and implications for, in silico screening of ligands for structure-guided drug design are, discussed.
+
The Mycobacterium tuberculosis rmlC gene encodes dTDP-4-keto-6-deoxyglucose epimerase, the third enzyme in the M. tuberculosis dTDP-L-rhamnose pathway which is essential for mycobacterial cell-wall synthesis. Because it is structurally unique, highly substrate-specific and does not require a cofactor, RmlC is considered to be the most promising drug target in the pathway, and the M. tuberculosis rmlC gene was selected in the initial round of TB Structural Genomics Consortium targets for structure determination. The 1.7 A native structure determined by the consortium facilities is reported and implications for in silico screening of ligands for structure-guided drug design are discussed.
==About this Structure==
==About this Structure==
-
1UPI is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis]. Active as [http://en.wikipedia.org/wiki/dTDP-4-dehydrorhamnose_3,5-epimerase dTDP-4-dehydrorhamnose 3,5-epimerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.1.3.13 5.1.3.13] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1UPI OCA].
+
1UPI is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis]. Active as [http://en.wikipedia.org/wiki/dTDP-4-dehydrorhamnose_3,5-epimerase dTDP-4-dehydrorhamnose 3,5-epimerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.1.3.13 5.1.3.13] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1UPI OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: dTDP-4-dehydrorhamnose 3,5-epimerase]]
[[Category: dTDP-4-dehydrorhamnose 3,5-epimerase]]
-
[[Category: Kantardjieff, K.A.]]
+
[[Category: Kantardjieff, K A.]]
-
[[Category: Kim, C.Y.]]
+
[[Category: Kim, C Y.]]
[[Category: Lekin, T.]]
[[Category: Lekin, T.]]
[[Category: Naranjo, C.]]
[[Category: Naranjo, C.]]
[[Category: Rupp, B.]]
[[Category: Rupp, B.]]
-
[[Category: Segelke, B.W.]]
+
[[Category: Segelke, B W.]]
-
[[Category: TBSGC, TB.Structural.Genomics.Consortium.]]
+
[[Category: TBSGC, TB Structural Genomics Consortium.]]
[[Category: Terwilliger, T.]]
[[Category: Terwilliger, T.]]
-
[[Category: Waldo, G.S.]]
+
[[Category: Waldo, G S.]]
[[Category: Zemla, A.]]
[[Category: Zemla, A.]]
[[Category: epimerase]]
[[Category: epimerase]]
Line 32: Line 32:
[[Category: tbsgc]]
[[Category: tbsgc]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Sun Nov 25 04:17:06 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:27:01 2008''

Revision as of 13:27, 21 February 2008


1upi, resolution 1.70Å

Drag the structure with the mouse to rotate

MYCOBACTERIUM TUBERCULOSIS RMLC EPIMERASE (RV3465)

Overview

The Mycobacterium tuberculosis rmlC gene encodes dTDP-4-keto-6-deoxyglucose epimerase, the third enzyme in the M. tuberculosis dTDP-L-rhamnose pathway which is essential for mycobacterial cell-wall synthesis. Because it is structurally unique, highly substrate-specific and does not require a cofactor, RmlC is considered to be the most promising drug target in the pathway, and the M. tuberculosis rmlC gene was selected in the initial round of TB Structural Genomics Consortium targets for structure determination. The 1.7 A native structure determined by the consortium facilities is reported and implications for in silico screening of ligands for structure-guided drug design are discussed.

About this Structure

1UPI is a Single protein structure of sequence from Mycobacterium tuberculosis. Active as dTDP-4-dehydrorhamnose 3,5-epimerase, with EC number 5.1.3.13 Full crystallographic information is available from OCA.

Reference

Mycobacterium tuberculosis RmlC epimerase (Rv3465): a promising drug-target structure in the rhamnose pathway., Kantardjieff KA, Kim CY, Naranjo C, Waldo GS, Lekin T, Segelke BW, Zemla A, Park MS, Terwilliger TC, Rupp B, Acta Crystallogr D Biol Crystallogr. 2004 May;60(Pt 5):895-902. Epub 2004, Apr 21. PMID:15103135

Page seeded by OCA on Thu Feb 21 15:27:01 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools